Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orthopediatrics Corp (NQ: KIDS )

22.12 +0.20 (+0.91%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 325,911
Open 21.87
Bid (Size) 21.04 (10)
Ask (Size) 27.20 (6)
Prev. Close 21.92
Today's Range 21.02 - 22.50
52wk Range 21.02 - 36.23
Shares Outstanding 19,672,616
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
Continues IPOS Corporate Partnership as Emerald-Level Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire

Performance

YTD
-32.99%
-32.99%
1 Month
-8.82%
-8.82%
3 Month
-31.47%
-31.47%
6 Month
-24.51%
-24.51%
1 Year
-31.09%
-31.09%

More News

Read More
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace
From OrthoPediatrics Corp.
Via GlobeNewswire
The Latest Analyst Ratings For OrthoPediatrics
Via Benzinga
The Latest Analyst Ratings For OrthoPediatrics
Via Benzinga
Expert Ratings For OrthoPediatrics
Via Benzinga
OrthoPediatrics Corp. to Participate in Upcoming Conferences
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
The Analyst Verdict: OrthoPediatrics In The Eyes Of 6 Experts
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For OrthoPediatrics
Via Benzinga
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
OrthoPediatrics Corp. Reports Second Quarter 2024 Financial Results and Reaffirms Full Year 2024 Revenue Guidance
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Private Financing
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Second Quarter 2024 Financial Results on August 6, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
From OrthoPediatrics Corp.
Via GlobeNewswire
KIDS Stock Earnings: OrthoPediatrics Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From OrthoPediatrics Corp.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.